{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:01:33Z","timestamp":1791900093198,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5520,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.nurt.2008.05.004","type":"journal-article","created":{"date-parts":[[2008,7,13]],"date-time":"2008-07-13T04:34:29Z","timestamp":1215923669000},"page":"470-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["Ketone Bodies as a Therapeutic for Alzheimer's Disease"],"prefix":"10.1016","volume":"5","author":[{"given":"Samuel T.","family":"Henderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2008.05.004_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.ne.19.030196.000413","article-title":"Apolipoprotein E and Alzheimer's disease","volume":"19","author":"Strittmatter","year":"1996","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.nurt.2008.05.004_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.exger.2006.05.016","article-title":"Early detection of Alzheimer's disease using neuroimaging","volume":"42","author":"Mosconi","year":"2007","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.nurt.2008.05.004_bib3","series-title":"Basic neurochemistry","first-page":"645","article-title":"Circulation and energy metabolism of the brain","author":"Clarke","year":"1994"},{"key":"10.1016\/j.nurt.2008.05.004_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tins.2004.06.005","article-title":"Energetic basis of brain activity: implications for neuroimaging","volume":"27","author":"Shulman","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.nurt.2008.05.004_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev.neuro.29.051605.112819","article-title":"Brain work and brain imaging","volume":"29","author":"Raichle","year":"2006","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.nurt.2008.05.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1440.011","article-title":"The brain's default network: anatomy, function, and relevance to disease","volume":"1124","author":"Buckner","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nurt.2008.05.004_bib7","first-page":"203","article-title":"Cerebral blood flow and metabolism in schizophrenia","volume":"151","author":"Kety","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.nurt.2008.05.004_bib8","series-title":"Glucose metabolism in the Brain","first-page":"159","article-title":"Expression, regulation, and functional role of glucose transporters (GLUTs) in brain","author":"Dwyer","year":"2002"},{"key":"10.1016\/j.nurt.2008.05.004_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ana.20331","article-title":"Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects","volume":"57","author":"Wang","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.05.004_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ng0298-188","article-title":"GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier","volume":"18","author":"Seidner","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.nurt.2008.05.004_bib11","first-page":"568","article-title":"Positron emission tomographic studies of aging and Alzheimer disease","volume":"4","author":"de Leon","year":"1983","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.nurt.2008.05.004_bib12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E","volume":"334","author":"Reiman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2008.05.004_bib13","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1073\/pnas.090106797","article-title":"Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease","volume":"97","author":"Small","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.004_bib14","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2008.05.004_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.004_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.1997.00550150035013","article-title":"No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes","volume":"54","author":"Corder","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2008.05.004_bib17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.58.5.743","article-title":"The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset","volume":"58","author":"Hirono","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.05.004_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jnnp.2003.014993","article-title":"Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease","volume":"75","author":"Mosconi","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2008.05.004_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/jnnp.64.6.742","article-title":"Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism","volume":"64","author":"Lehtovirta","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2008.05.004_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0404.2006.00679.x","article-title":"Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology","volume":"185","author":"Mahley","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.nurt.2008.05.004_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.mito.2007.06.001","article-title":"Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease","volume":"7","author":"Atamna","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.nurt.2008.05.004_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/152165401753311780","article-title":"Ketone bodies, potential therapeutic uses","volume":"51","author":"Veech","year":"2001","journal-title":"IUBMB Life"},{"key":"10.1016\/j.nurt.2008.05.004_bib23","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0709259105","article-title":"Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons","volume":"105","author":"Liang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.004_bib24","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.1016\/S0021-9258(17)36875-8","article-title":"Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative","volume":"269","author":"Gabuzda","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.004_bib25","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.1523\/JNEUROSCI.2350-05.2005","article-title":"Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis","volume":"25","author":"Velliquette","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2008.05.004_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.plefa.2007.10.019","article-title":"Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies","volume":"77","author":"Calon","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.nurt.2008.05.004_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.mehy.2003.11.028","article-title":"High carbohydrate diets and Alzheimer's disease","volume":"62","author":"Henderson","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.nurt.2008.05.004_bib28","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI105650","article-title":"Brain metabolism during fasting","volume":"46","author":"Owen","year":"1967","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2008.05.004_bib29","doi-asserted-by":"crossref","first-page":"26649","DOI":"10.1074\/jbc.C500213200","article-title":"(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G","volume":"280","author":"Taggart","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.004_bib30","first-page":"41","article-title":"The metabolism of bovine epididymal spermatazoa","volume":"6","author":"Lardy","year":"1945","journal-title":"Arch Biochem"},{"key":"10.1016\/j.nurt.2008.05.004_bib31","first-page":"53","article-title":"Studies of fat and carbohydrate oxidation in mammalian spermatozoa","volume":"6","author":"Lardy","year":"1945","journal-title":"Arch Biochem"},{"key":"10.1016\/j.nurt.2008.05.004_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1096\/fasebj.9.8.7768357","article-title":"Insulin, ketone bodies, and mitochondrial energy transduction","volume":"9","author":"Sato","year":"1995","journal-title":"Faseb J"},{"key":"10.1016\/j.nurt.2008.05.004_bib33","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI200318797","article-title":"D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease","volume":"112","author":"Tieu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2008.05.004_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00008877-200609000-00009","article-title":"Neuroprotective and disease-modifying effects of the ketogenic diet","volume":"17","author":"Gasior","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.nurt.2008.05.004_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.jcbfm.9600543","article-title":"Cerebral metabolic adaptation and ketone metabolism after brain injury","volume":"28","author":"Prins","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nurt.2008.05.004_bib36","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M502456200","article-title":"Ketone bodies stimulate chaperone-mediated autophagy","author":"Finn","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.004_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1474-4422(07)70076-5","article-title":"Autophagy and neurodegeneration: when the cleaning crew goes on strike","volume":"6","author":"Martinez-Vicente","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nurt.2008.05.004_bib38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.biochem.75.103004.142637","article-title":"Axonal transport and Alzheimer's disease","volume":"75","author":"Stokin","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.nurt.2008.05.004_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.eplepsyres.2005.10.003","article-title":"The ketogenic diet: from molecular mechanisms to clinical effects","volume":"68","author":"Freeman","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.nurt.2008.05.004_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-2005-872843","article-title":"Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively","volume":"36","author":"Klepper","year":"2005","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nurt.2008.05.004_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2202-7-29","article-title":"A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis","volume":"7","author":"Zhao","year":"2006","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.nurt.2008.05.004_bib42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jnr.20633","article-title":"Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury","volume":"82","author":"Prins","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nurt.2008.05.004_bib43","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","article-title":"Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study","volume":"64","author":"Vanitallie","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.05.004_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-7075-2-28","article-title":"A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease","volume":"2","author":"Van der Auwera","year":"2005","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.nurt.2008.05.004_bib45","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1074\/jbc.274.10.6483","article-title":"Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain","volume":"274","author":"Moechars","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2008.05.004_bib46","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Ho","year":"2004","journal-title":"Faseb J"},{"key":"10.1016\/j.nurt.2008.05.004_bib47","first-page":"315","article-title":"Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet","volume":"6","author":"Levin-Allerhand","year":"2002","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.nurt.2008.05.004_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-7075-2-27","article-title":"When is a high fat diet not a high fat diet?","volume":"2","author":"Feinman","year":"2005","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.nurt.2008.05.004_bib49","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/ana.20062","article-title":"The ketogenic diet increases mitochondrial uncoupling protein levels and activity","volume":"55","author":"Sullivan","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.05.004_bib50","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/jnr.20736","article-title":"Acetoacetate protects neuronal cells from oxidative glutamate toxicity","volume":"83","author":"Noh","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nurt.2008.05.004_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1254\/jjp.89.36","article-title":"Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia","volume":"89","author":"Suzuki","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.nurt.2008.05.004_bib52","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","article-title":"D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease","volume":"97","author":"Kashiwaya","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2008.05.004_bib53","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/ajcn\/36.5.950","article-title":"Medium-chain triglycerides: an update","volume":"36","author":"Bach","year":"1982","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nurt.2008.05.004_bib54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0197-4580(03)00087-3","article-title":"Effects of beta-hydroxybutyrate on cognition in memory-impaired adults","volume":"25","author":"Reger","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nurt.2008.05.004_bib55","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.2000.tb06371.x","article-title":"Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype","volume":"903","author":"Craft","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nurt.2008.05.004_bib56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nurt.2008.05.004_bib57","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.nurt.2008.05.004_bib58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"issue":"Pt 2","key":"10.1016\/j.nurt.2008.05.004_bib59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3430281","article-title":"The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation","volume":"343","author":"Halestrap","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.nurt.2008.05.004_bib60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00001756-200103260-00030","article-title":"Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues","volume":"12","author":"Froberg","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.nurt.2008.05.004_bib61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1980.60.1.143","article-title":"Physiological roles of ketone bodies as substrates and signals in mammalian tissues","volume":"60","author":"Robinson","year":"1980","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nurt.2008.05.004_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0920-1211(02)00262-0","article-title":"The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice","volume":"53","author":"Noh","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.nurt.2008.05.004_bib63","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1469-8749.2007.00707.x","article-title":"GLUT1 deficiency syndrome\u20142007 update","volume":"49","author":"Klepper","year":"2007","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nurt.2008.05.004_bib64","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0306-4522(03)00266-5","article-title":"Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition","volume":"120","author":"Massieu","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.nurt.2008.05.004_bib65","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11064-006-9189-5","article-title":"D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo","volume":"31","author":"Mejia-Toiber","year":"2006","journal-title":"Neurochem Res"},{"key":"10.1016\/j.nurt.2008.05.004_bib66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2006.11.065","article-title":"Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation","volume":"145","author":"Maalouf","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.nurt.2008.05.004_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jnr.20464","article-title":"D-beta-hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures","volume":"80","author":"Masuda","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nurt.2008.05.004_bib68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1254\/jjp.87.143","article-title":"Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats","volume":"87","author":"Suzuki","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.nurt.2008.05.004_bib69","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1471-4159.2004.02542.x","article-title":"Increased cerebral uptake and oxidation of exogenous beta HB improves ATP following traumatic brain injury in adult rats","volume":"90","author":"Prins","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.nurt.2008.05.004_bib70","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/jnr.21021","article-title":"D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease","volume":"84","author":"Imamura","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nurt.2008.05.004_bib71","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1203\/00006450-200008000-00021","article-title":"Increased plasma beta-hydroxybutyrate, preserved cerebral energy metabolism, and amelioration of brain damage during neonatal hypoxia ischemia with dexamethasone pretreatment","volume":"48","author":"Dardzinski","year":"2000","journal-title":"Pediatr Res"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923004920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923004920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2008.05.004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:38:56Z","timestamp":1761806336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923004920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1878747923004920"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2008.05.004","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketone Bodies as a Therapeutic for Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2008.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}